case_images: PMC11785861_01
case_images: The clinical course of the patient. Changes in the cell counts in the dialysis effluent (orange lines), the white blood cell count (WBC, yellow lines), and the platelet count (PLT, blue lines). MEPM: meropenem, VCM: vancomycin
case_images: 13730_2024_894_Fig1_HTML.jpg
case_images: PMC11785861_01_13730_2024_894_Fig1_HTML.jpg
case_images: Fig1
case_images: We administered 0.5 mg/day of meropenem (MPEM) and 1.0 mg of vancomycin (VCM) intravenously to treat the PD-associated peritonitis (Fig. 1), and the cell counts in the dialysis effluent gradually decreased alongside the antibiotic treatment but there was no amelioration of the patient's abdominal pain.
case_images: Enhanced computed tomography (CT) findings. Enhanced CT revealed thrombosis of the superior mesenteric artery (SMA) (A), calcification of origin of SMA (B) and intestinal necrosis (C)
case_images: 13730_2024_894_Fig2_HTML.jpg
case_images: PMC11785861_01_13730_2024_894_Fig2_HTML.jpg
case_images: Fig2
case_images: Abdominal CT revealed severe calcification of SMA, SMA thrombosis and intestinal necrosis, but no findings indicative of intestinal perforation (Fig. 2).